PURPOSE: Early detection of infectious endocarditis is challenging. For diagnosing infectious endocarditis, the revised Duke criteria are the gold standard. Evidence of endocardial involvement on echocardiography is a major criterion, but sensitivity and specificity of echocardiography are not optimal. Here we investigated the utility of (18)F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) to diagnose infectious endocarditis in patients with gram-positive bacteraemia. METHODS: Seventy-two patients with gram-positive bacteraemia were prospectively included. Patients with a positive blood culture growing Staphylococcus aureus, Streptococcus species or Enterococcus species were eligible when a risk factor for developing metastatic infectious foci was present. Infectious endocarditis was defined according to the revised Duke criteria. All patients underwent (18)F-FDG PET/CT and echocardiography. (18)F-FDG uptake in or around the heart valves was evaluated independently by two nuclear medicine physicians. RESULTS: Sensitivity for diagnosing infectious endocarditis with (18)F-FDG PET/CT was 39% and specificity was 93%. The positive predictive value was 64% and negative predictive value was 82%. The mortality rate in patients without infectious endocarditis and without increased (18)F-FDG uptake in or around the heart valves was 18%, and in patients without infectious endocarditis but with high (18)F-FDG uptake in or around the heart valves the mortality rate was 50% (p = 0.181). CONCLUSION: (18)F-FDG PET/CT is currently not sufficiently adequate for the diagnosis of infectious endocarditis because of its low sensitivity. Improvements such as patient preparation with low carbohydrate-fat allowed diet and technical advances in the newest PET/CT scanners may increase sensitivity in future studies.
PURPOSE: Early detection of infectious endocarditis is challenging. For diagnosing infectious endocarditis, the revised Duke criteria are the gold standard. Evidence of endocardial involvement on echocardiography is a major criterion, but sensitivity and specificity of echocardiography are not optimal. Here we investigated the utility of (18)F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) to diagnose infectious endocarditis in patients with gram-positive bacteraemia. METHODS: Seventy-two patients with gram-positive bacteraemia were prospectively included. Patients with a positive blood culture growing Staphylococcus aureus, Streptococcus species or Enterococcus species were eligible when a risk factor for developing metastatic infectious foci was present. Infectious endocarditis was defined according to the revised Duke criteria. All patients underwent (18)F-FDG PET/CT and echocardiography. (18)F-FDG uptake in or around the heart valves was evaluated independently by two nuclear medicine physicians. RESULTS: Sensitivity for diagnosing infectious endocarditis with (18)F-FDG PET/CT was 39% and specificity was 93%. The positive predictive value was 64% and negative predictive value was 82%. The mortality rate in patients without infectious endocarditis and without increased (18)F-FDG uptake in or around the heart valves was 18%, and in patients without infectious endocarditis but with high (18)F-FDG uptake in or around the heart valves the mortality rate was 50% (p = 0.181). CONCLUSION: (18)F-FDG PET/CT is currently not sufficiently adequate for the diagnosis of infectious endocarditis because of its low sensitivity. Improvements such as patient preparation with low carbohydrate-fat allowed diet and technical advances in the newest PET/CT scanners may increase sensitivity in future studies.
Authors: J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey Journal: Clin Infect Dis Date: 2000-04-03 Impact factor: 9.079
Authors: F J Vos; C P Bleeker-Rovers; P D Sturm; P F M Krabbe; A P J van Dijk; W J G Oyen; B J Kullberg Journal: Neth J Med Date: 2011 Jul-Aug Impact factor: 1.422
Authors: Siamak Moghadam-Kia; Asad Nawaz; B Cherie Millar; John E Moore; Susan E Wiegers; Drew A Torigian; Sandip Basu; Abass Alavi Journal: Hell J Nucl Med Date: 2009 May-Aug Impact factor: 1.102
Authors: Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert Journal: Circulation Date: 2005-06-14 Impact factor: 29.690
Authors: Ludovic Le Meunier; Piotr J Slomka; Damini Dey; Amit Ramesh; Louis E J Thomson; Sean W Hayes; John D Friedman; Victor Cheng; Guido Germano; Daniel S Berman Journal: J Nucl Cardiol Date: 2010-12-16 Impact factor: 5.952
Authors: Paola A Erba; Umberto Conti; Elena Lazzeri; Martina Sollini; Roberta Doria; Salvatore M De Tommasi; Francesco Bandera; Carlo Tascini; Francesco Menichetti; Rudi A J O Dierckx; Alberto Signore; Giuliano Mariani Journal: J Nucl Med Date: 2012-07-11 Impact factor: 10.057
Authors: Siegbert Rieg; Gabriele Peyerl-Hoffmann; Katja de With; Christian Theilacker; Dirk Wagner; Johannes Hübner; Markus Dettenkofer; Achim Kaasch; Harald Seifert; Christian Schneider; Winfried V Kern Journal: J Infect Date: 2009-08-03 Impact factor: 6.072
Authors: Ana Jiménez-Ballvé; María Jesús Pérez-Castejón; Roberto C Delgado-Bolton; Cristina Sánchez-Enrique; Isidre Vilacosta; David Vivas; Carmen Olmos; Manuel E Fuentes Ferrer; José L Carreras-Delgado Journal: Eur J Nucl Med Mol Imaging Date: 2016-09-05 Impact factor: 9.236